enVVeno Medical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVNO and other ETFs, options, and stocks.About NVNO
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe.
CEORobert Andrew Berman
CEORobert Andrew Berman
Employees37
Employees37
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded1999
Founded1999
Employees37
Employees37
NVNO Key Statistics
Market cap6.43M
Market cap6.43M
Price-Earnings ratio-0.28
Price-Earnings ratio-0.28
Dividend yield—
Dividend yield—
Average volume34.70K
Average volume34.70K
High today—
High today—
Low today—
Low today—
Open price$10.90
Open price$10.90
Volume0.00
Volume0.00
52 Week high$196.70
52 Week high$196.70
52 Week low$9.81
52 Week low$9.81
Stock Snapshot
As of today, enVVeno Medical(NVNO) shares are valued at $10.92. The company's market cap stands at 6.43M, with a P/E ratio of -0.28.
During the trading day, enVVeno Medical(NVNO) stock saw an opening price of $10.90, a peak of —, and a bottom of —.
Trading volume for enVVeno Medical(NVNO) stock has reached 0, versus its average volume of 34.7K.
Over the past 52 weeks, enVVeno Medical(NVNO) stock has traded between a high of $196.70 and a low of $9.81.
Over the past 52 weeks, enVVeno Medical(NVNO) stock has traded between a high of $196.70 and a low of $9.81.
NVNO News
TipRanks 3d
enVVeno Medical Executes One-for-35 Reverse Stock SplitClaim 50% Off TipRanks Premium enVVeno Medical ( (NVNO) ) just unveiled an update. On January 20, 2026, enVVeno Medical Corporation implemented a one-for-35 r...
People also own
Based on the portfolios of people who own NVNO. This list is generated using Robinhood data, and it’s not a recommendation.